A Transient Upregulation of Glutamine Synthetase in the Dentate Gyrus Is Involved in Epileptogenesis Induced by Amygdala Kindling in the Rat
Open Access
- 18 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e66885
Abstract
Reduction of glutamine synthetase (GS) function is closely related to established epilepsy, but little is known regarding its role in epileptogenesis. The present study aimed to elucidate the functional changes of GS in the brain and its involvement in epileptogenesis using the amygdala kindling model of epilepsy induced by daily electrical stimulation of basolateral amygdala in rats. Both expression and activity of GS in the ipsilateral dentate gyrus (DG) were upregulated when kindled seizures progressed to stage 4. A single dose of L-methionine sulfoximine (MSO, in 2 µl), a selective GS inhibitor, was administered into the ipsilateral DG on the third day following the first stage 3 seizure (just before GS was upregulated). It was found that low doses of MSO (5 or 10 µg) significantly and dose-dependently reduced the severity of and susceptibility to evoked seizures, whereas MSO at a high dose (20 µg) aggravated kindled seizures. In animals that seizure acquisition had been successfully suppressed with 10 µg MSO, GS upregulation reoccurred when seizures re-progressed to stage 4 and re-administration of 10 µg MSO consistently reduced the seizures. GLN at a dose of 1.5 µg abolished the alleviative effect of 10 µg MSO and deleterious effect of 20 µg MSO on kindled seizures. Moreover, appropriate artificial microRNA interference (1 and 1.5×106 TU/2 µl) of GS expression in the ipsilateral DG also inhibited seizure progression. In addition, a transient increase of GS expression and activity in the cortex was also observed during epileptogenesis evoked by pentylenetetrazole kindling. These results strongly suggest that a transient and region-specific upregulation of GS function occurs when epilepsy develops into a certain stage and eventually promotes the process of epileptogenesis. Inhibition of GS to an adequate degree and at an appropriate timing may be a potential therapeutic approach to interrupting epileptogenesis.Keywords
This publication has 38 references indexed in Scilit:
- Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsyNeurobiology of Disease, 2012
- Therapeutic time window of low‐frequency stimulation at entorhinal cortex for amygdaloid‐kindling seizures in ratsEpilepsia, 2010
- Maintenance of Thalamic Epileptiform Activity Depends on the Astrocytic Glutamate-Glutamine CycleJournal of Neurophysiology, 2009
- Haploinsufficiency of glutamine synthetase increases susceptibility to experimental febrile seizuresGenes, Brain and Behavior, 2009
- Low-frequency stimulation of the tuberomammillary nucleus facilitates electrical amygdaloid-kindling acquisition in Sprague–Dawley ratsNeurobiology of Disease, 2008
- Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in ratsBrain, 2008
- Modulation of epileptiform activity by glutamine and system A transport in a model of post-traumatic epilepsyNeurobiology of Disease, 2007
- Reversible inhibition of mammalian glutamine synthetase by tyrosine nitrationFEBS Letters, 2006
- Hippocampal Formation2004
- The glutamine commuteJournal of Cell Biology, 2002